Pfizer BioNTech’s COVID-19 vaccine is allegedly being made available to anyone aged between 12 to 15 in Europe. The chief executive of the German company confirmed that Pfizer has submitted an application for emergency approval of this vaccine for this particular age group in the US at the start of April, being ready for submission to the European Medicines Agency as well by next Wednesday. Being approved for 16-year-olds and over, the prospect of vaccinating younger children could be a crucial next step towards herd immunity.
Vaccinating children before the next school year is also another reason why the vaccine is being considered for approval as it eases strain on parents worrying about their children’s health. Participants in Pfizer’s studies showed positive results as the vaccine provided an incredible 100% protection.
#MaltaDaily
Photo Source: Bloomsberg.com